Clinical Pharmacy oncology

Cervical cancer

Topic overview

Start with the big picture

The lesson connects persistent high-risk HPV infection with cervical cancer development and reviews behavioral and biological factors that can increase risk. It outlines HPV vaccination and routine screening as prevention and early-detection strategies, then introduces major histological subtypes and FIGO staging, including the significance of nodal metastasis. Management is organized by disease extent: early-stage options include surgery, with fertility-preserving approaches for selected patients; locally advanced disease commonly involves radiotherapy with concurrent chemotherapy; and recurrent or metastatic disease may be treated with systemic regimens. The topic also considers treatment-related toxicities, supportive care, and monitoring needs such as blood counts, renal function, electrolytes, blood pressure, and neuropathy.

Learning objectives

What you'll learn

  • Explain the role of persistent high-risk HPV infection in cervical cancer.
  • Identify key risk factors and prevention strategies, including vaccination and screening.
  • Describe the histological subtypes and staging concepts covered in the lesson.
  • Compare treatment approaches for early-stage, locally advanced, and recurrent or metastatic disease.
  • Recognize major treatment toxicities and relevant monitoring and supportive-care measures.
Ready for the complete lesson?

Continue your study

Work through the complete notes and reinforce the topic with the study tools available in the full lesson.

PharmaProLearn

Excel Beyond Limits